Drug Information

Drug General Information
Drug ID
D0UE0S
Former ID
DIB019472
Drug Name
compound 3b
Drug Type
Small molecular drug
Indication Discovery agent Investigative [532250]
Formula
C25H30N4O7
InChI
InChI=1S/C25H30N4O7/c26-7-8-31-9-10-32-11-12-33-13-14-34-20-4-2-19(3-5-20)27-25-28-21(24(30)29-25)15-18-1-6-22-23(16-18)36-17-35-22/h1-6,15-16H,7-14,17,26H2,(H2,27,28,29,30)/b21-15-
InChIKey
ZBYBDKHFLSHGBP-QNGOZBTKSA-N
PubChem Compound ID
71653343
PubChem Substance ID
163815911, 194166145, 194941534, 249565807
Target and Pathway
Target(s) dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 Target Info Inhibitor [532250]
CDC-like kinase 2 Target Info Inhibitor [532250]
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A Target Info Inhibitor [532250]
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B Target Info Inhibitor [532250]
Cdc2-like kinase 1 Target Info Inhibitor [532250]
CDC-like kinase 3 Target Info Inhibitor [532250]
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 Target Info Inhibitor [532250]
CDC-like kinase 4 Target Info Inhibitor [532250]
NetPath Pathway TCR Signaling Pathway
EGFR1 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
WikiPathways mRNA Processing
References
Ref 532250Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines. Eur J Med Chem. 2013 Apr;62:728-37.
Ref 532250Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines. Eur J Med Chem. 2013 Apr;62:728-37.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.